Tower Research Capital »

Coeptis Therapeutics Hldgs I shares owned by Tower Research Capital

Quarter-by-quarter ownership of Coeptis Therapeutics Hldgs I (COEP) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Coeptis Therapeutics Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Coeptis Therapeutics Hldgs I held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coeptis Therapeutics Hldgs I by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-06-30 $2.1k 268 7.80
2025-03-31 $6.3k 675 9.37
2024-12-31 $4.0k 723 5.50

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Coeptis Therapeutics Hldgs I

Vanguard Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
Yorkville Advisors Global
Steward Partners Investment Advisory
Pnc Financial Services
Barclays

View all funds holding Coeptis Therapeutics Hldgs I